Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia.

There is no current approved therapy for the ultimately lethal neuro- and cardio-degenerative disease Friedreich's ataxia (FA). Finding minimally-invasive molecular biomarkers of disease progression and drug effect could support smaller, shorter clinical trials. Since we and others have noted a...

詳細記述

書誌詳細
主要な著者: Genki Hayashi, Gino Cortopassi
フォーマット: 論文
言語:English
出版事項: Public Library of Science (PLoS) 2016-01-01
シリーズ:PLoS ONE
オンライン・アクセス:http://europepmc.org/articles/PMC4831832?pdf=render

類似資料